To access this element change to forms mode OFF
Grant Award View - GA205193
Illumination of Immune Checkpoint Therapy of Cancer: Molecular Imaging...
GA ID:
GA205193
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
13-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 1-Jan-2025
Value (AUD):
$515,103.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Illumination of Immune Checkpoint Therapy of Cancer: Molecular Imaging of Immunity with Copper Radiopharmaceuticals
Purpose:
Exciting developments in the treatment of cancer have involved developing ways to reinvigorate a patient’s own immune system to attack their disease. This type of therapy, called immune checkpoint therapy, produces remarkable outcomes for some patients but some do not respond. This research will develop the chemistry required to produce imaging agents to enable clinicians to identify patients suitable for immune checkpoint therapies using non-invasive Positron Emission Tomography (PET) imaging.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011853
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC
Postcode:
Multiple
Country:
AUSTRALIA